DS Healthcare (DSKX) Narrows Q3 Loss

DS Healthcare (NASDAQ: DSKX) reported Q3 EPS of $0.00, versus ($0.08) reported last year. Revenue for the quarter came in at $3.3 million, versus $3.2 million reported last year.

For earnings history and earnings-related data on DS Healthcare (DSKX) click here.

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• Nebius Group (NBIS) PT Raised to $300 at Compass Point
• Pelthos Therapeutics Inc. (PTHS) Misses Q2 EPS by 611c